LinkOPH

VIENNA — Following the conclusions of DRCR.net Protocol S, anti-VEGFs are likely to be used more and earlier in the treatment of proliferative diabetic retinopathy. At the Advanced Retinal Therapy meeting, Simon Harding, MD, chair of Clinical Ophthalmology at Liverpool University, U.K., expressed concern about the rising costs of therapy in future years.In Liverpool, in a diabetic population of 22,432, 856 laser procedures were performed in 319 patients in 2015. Based on a previous audit, it can be assumed that about 50% of these patients had proliferative diabetic retinopathy.

Read more →

An institutional audit of the electronic health record system used by internal medicine house staff found that residents spent more than 30% of their time using the system, according to data published in JAMA Internal Medicine. David Ouyang, MD, i…

Read more →

VIENNA — At the Advanced Retinal Therapy meeting, André Romano, MD, talks about the state of the art of OCT angiography and highlights the advantages of this technique in comparison with the gold standard fluorescein angiography.

Read more →

Ocular Therapeutix reported a net loss of $11.5 million, or $0.47 per share, in the third quarter compared with a net loss of $7.3 million, or $0.48, per share in the same quarter of 2014, according to a press release. Product sales from ReSure sealant…

Read more →

A low-power multifocal toric IOL benefited patients with low degrees of astigmatism, according to a study.The retrospective study included 76 eyes of 63 cataract patients who received an SN6AT2 AcrySof IQ monofocal toric IOL (Alcon) and 44 eyes of 44 p…

Read more →